Literature DB >> 2835724

Specific tissue targeting of polyoma virus oncogenicity in athymic nude mice.

M Berebbi1, L Dandolo, J Hassoun, A M Bernard, D Blangy.   

Abstract

Inbred athymic nu/nu mice (BALB/c and C57BL/6) were injected subcutaneously with polyoma virus A2 strain or with polyoma mutants which are able to infect undifferentiated embryonal carcinoma cells and harbor mutations in their enhancer sequences. Mammary adenocarcinomas were induced exclusively in females in which they represent the majority of the tumors. Both males and females developed sarcomas, mostly osteosarcomas, with a similar low frequency. No other type of neoplasm was observed. Mutations affecting the enhancers do not have any effect on the histotype of the tumors. Multiple copies of intact or defective free viral DNA were detected in all tumors. Such a sex-linked specific tissue targeting suggests a hormonal control of tumor initiation and/or promotion. From a pathological point of view, polyoma-induced adenocarcinomas are very similar to human early breast cancers. Tumor induction in nude mice by polyoma virus therefore represents a unique experimental model which differs from the more extensively used newborn immunocompetent mice.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2835724

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

Review 1.  Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.

Authors:  Michele M Fluck; Brian S Schaffhausen
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

2.  Protection against polyoma virus-induced tumors is perforin-independent.

Authors:  Anthony M Byers; Annette Hadley; Aron E Lukacher
Journal:  Virology       Date:  2006-09-28       Impact factor: 3.616

3.  Mutations of polyomavirus VP1 allow in vitro growth in undifferentiated cells and modify in vivo tissue replication specificity.

Authors:  B Mezes; P Amati
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

4.  Episomal amplification or chromosomal integration of the viral genome: alternative pathways in hamster polyomavirus-induced lymphomas.

Authors:  S Mazur; J Feunteun; C de La Roche Saint André
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

5.  Viral genomes maintained extrachromosomally in hamster polyomavirus-induced lymphomas display a cell-specific replication in vitro.

Authors:  C de La Roche Saint André; S Mazur; J Feunteun
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

6.  The polyomavirus early region gene in transgenic mice causes vascular and bone tumors.

Authors:  R Wang; V L Bautch
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

7.  Immunological elimination of infected cells as the candidate mechanism for tumor protection in polyomavirus-infected mice.

Authors:  J J Wirth; M M Fluck
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

8.  In vivo replication of the hamster polyomavirus genome and generation of specific deletions in the process of lymphomagenesis.

Authors:  S Mazur; M Goodhardt; J Feunteun; C de La Roche Saint André
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

9.  Different roles for two enhancer domains in the organ- and age-specific pattern of polyomavirus replication in the mouse.

Authors:  A Amalfitano; L G Martin; M M Fluck
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

10.  Acute, lethal, natural killer cell-resistant myeloproliferative disease induced by polyomavirus in severe combined immunodeficient mice.

Authors:  E Szomolanyi-Tsuda; P L Dundon; I Joris; L D Shultz; B A Woda; R M Welsh
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.